MLTX
Moonlake Immunotherapeutics
$65.71M
Cluster sell
Discretionary Insider Activity
Date:
03/31/2026
Insiders:
BVF PARTNERS L P/IL, director, and 1 others
Prior trend:
6 months of no clear discretionary insider activity

Summary

A $65.71M cluster sell for Moonlake Immunotherapeutics (MLTX) on 03/31/2026 after 6 months of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Sell $62.96M 04/02/2026 BVF PARTNERS L P/IL + 17 Director, a 10%+ owner 0000921895-26-000895
Sell $2.75M 04/14/2026 Santos da Silva Jorge Director, Chief Executive Officer 0001213900-26-043647

Stake Changes

Action Insider Role(s) Total Change % Change
BVF PARTNERS L P/IL Director, a 10%+ owner unknown unknown
Sell Santos da Silva Jorge Director, Chief Executive Officer $2.75M 4.9%

Transactions

Action Amount Date Insider Security Type SEC Code
Sell $32.44M 03/31/2026 BVF PARTNERS L P/IL Class A Ordinary Shares, $0.0001 par value Discretionary Sale
Sell $26.35M 03/31/2026 BVF PARTNERS L P/IL Class A Ordinary Shares, $0.0001 par value Discretionary Sale
Sell $4.17M 03/31/2026 BVF PARTNERS L P/IL Class A Ordinary Shares, $0.0001 par value Discretionary Sale
Sell $1.81M 04/10/2026 Santos da Silva Jorge Class A ordinary shares, par value $0.0001 per share Discretionary Sale
Sell $946K 04/13/2026 Santos da Silva Jorge Class A ordinary shares, par value $0.0001 per share Discretionary Sale

Stats

Prior max multiple:
1,128.1
Prior median multiple:
1,128.1

Metadata

Signal ID:
FUWKezj9EVGmqV4E
Scanned on:
05/06/2026
Status:
Current